ReviewActa gastroenterologica Latinoamericana
[Gastric Intestinal Metaplasia: an Update on Epidemiology, Diagnosis, Risk Stratification, and Clinical Management].
Review in Acta gastroenterologica Latinoamericana. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
GIM is one of the main premalignant lesions in the intestinal-type gastric adenocarcinoma carcinogenesis sequence described by Correa. Its identification represents one of the cornerstones of secondary gastric cancer prevention, as it allows the selection of patients at higher risk of progression and the establishment of individualized surveillance programs. In recent years, significant advances have been made in the pathophysiological understanding of intestinal metaplasia and in endoscopic diagnostic techniques. Among the most relevant advances are virtual chromoendoscopy, the EGGIM classification, the OLGA and OLGIM histological systems, and the progressive incorporation of artificial intelligence. Current clinical guidelines have reinforced the role of high-quality endoscopy, individualized risk stratification, and systematic Helicobacter pylori eradication. This review summarizes the most recent evidence on the epidemiology, pathophysiology, classification, diagnosis, risk stratification, and clinical management of GIM, comparing the main international guidelines and incorporating perspectives on the application of artificial intelligence to gastrointestinal endoscopy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.